oral semaglutide nejm and Cardiovascular Outcomes in Type 2 Diabetes Semaglutide and Cardiovascular Outcomes in

While the medication is generally increased over time, some people find that a lower "maintenance dose is still effective while curbing side effects

This blog post takes a deep dive into what this means for patients, separating fact from fear, and helping you understand how to balance the benefits and risks of GLP-1 therapy

Vanwege een wereldwijd tekort aan semaglutide is geadviseerd om dit middel niet off-label voor te schrijven als afslankmiddel, daavoor is Wegovy immers bedoeld

Safety monitoring: Injections have established protocols

Diarrhoea may contribute to the rapid intestinal transit that causes green stools